Skip to content

An ayurvedic formulation â??Chirbilwadi yogaâ?? useful in â??Sandhivataâ??

Pharmaco-clinical evaluation of Vednasthapana (Analgesic) activities of â??Chirbilwadi yogaâ?? w.s.r.â??Sandhivataâ?? (Osteoarthritis)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/03/006765
Enrollment
40
Registered
2016-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient suffering from sandhi shool sandhi sotha and Akunchana Prasaranajanya Vedana

Interventions

Intervention1: Chirbilwadi Yoga: 10 gm in 2 divided doses (5 gm each) Luke warm water Orally Bhojanottara 4 weeks Control Intervention1: Chirbilwadi patra swarasa bhavita chirbilwadi Yoga: 10 gm in

Sponsors

IPGT and RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Uncomplicated case of Sandhigata Vata. 2.Patients having primary osteoarthritis and degenerative osteoarthritis. 3.Patient fulfilling the diagnostic criteria of the Sandhivata and willing to participate in research trial.

Exclusion criteria

Exclusion criteria: 1)Patients will below 30 and above 70 years of age. 2)Patients suffering from disease like uncontrolled D.M. and Hypertension, Carcinoma, Psoriatic arthritis, Vatarakta, Amavata, S.L.E., Polymyalgia Rheumatica, Tuberculosis and other pathological conditions will be excluded. 3)Patients having secondary arthritis and severe characteristics of deformities.

Design outcomes

Primary

MeasureTime frame
Relief in the symptoms of sandhivataTimepoint: Relief in the symptoms of sandhivata after 7days ,14days,21 days,28days of treatement

Secondary

MeasureTime frame
Gatra shula(bodyache) Angamarda(Mucular weakness) Klama (fatigue without work) Alasya (Lethargy) Aruchi (Anorexia) Timepoint: Up to 28 days

Countries

India

Contacts

Public ContactPooja Rohilla

IPGT and RA

dr.poojarohilla06@gmail.com9904562033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026